quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:56:08·1590d
INSIDERFiling
Kansas City Southern logo

SEC Form 4: Beebe Lydia I gifted 3,559 shares and returned 2,028 shares to the company, closing all direct ownership in the company

KSU· Kansas City Southern
Transportation
Original source

Companies

  • KSU
    Kansas City Southern
    Transportation

Recent analyst ratings

  • Oct 20UpdateWolfe Research-
  • Oct 20UpdateRaymond James$319.00
  • Oct 14UpdateRaymond James$316.00
  • Oct 7UpdateWells Fargo$300.00
  • Oct 6UpdateCitigroup$300.00
  • Oct 4UpdateBarclays$275.00

Related

  • 13D/G1570d
    SEC Form SC 13G/A filed by Kansas City Southern (Amendment)
  • SEC1578d
    SEC Form 15-12B filed by Kansas City Southern
  • 13D/G1585d
    SEC Form SC 13G filed by Kansas City Southern
  • INSIDER1590d
    SEC Form 4: Cheatum Lora S covered exercise/tax liability with 567 shares and returned 17,159 shares to the company, closing all direct ownership in the company (for tax liability)
  • INSIDER1590d
    SEC Form 4: Cordova Lu M returned 10,031 shares to the company, closing all direct ownership in the company
  • INSIDER1590d
    SEC Form 4: Del Cueto Cuevas Oscar Augusto covered exercise/tax liability with 145 shares and returned 6,360 shares to the company, closing all direct ownership in the company to cover taxes
  • INSIDER1590d
    SEC Form 4: Druten Robert J converted options into 341 shares and returned 21,393 shares to the company, closing all direct ownership in the company to satisfy withholding obligation
  • INSIDER1590d
    SEC Form 4: Erdman Warren K gifted 2,550 shares, covered exercise/tax liability with 692 shares and returned 54,374 shares to the company, closing all direct ownership in the company (withholding tax)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022